Business · 19/10/1994Updated: 10/18/2026 · 1 min read
King Pharmaceuticals, Inc., et al.; FDA Withdraws Approval of 27 Abbreviated New Drug Applications
Summary
The US Food and Drug Administration (FDA) has withdrawn the approval of 27 abbreviated new drug applications (ANDA's) following notification from the applicants that the corresponding drug products are no longer commercially available.
Original source language: Federal Register — Health and Human ServicesOpen original release →